دورية أكاديمية

Success rates of probing for congenital nasolacrimal duct obstruction at various ages

التفاصيل البيبلوغرافية
العنوان: Success rates of probing for congenital nasolacrimal duct obstruction at various ages
المؤلفون: Marta Świerczyńska, Ewelina Tobiczyk, Piotr Rodak, Dorota Barchanowska, Erita Filipek
المصدر: BMC Ophthalmology, Vol 20, Iss 1, Pp 1-8 (2020)
بيانات النشر: BMC, 2020.
سنة النشر: 2020
المجموعة: LCC:Ophthalmology
مصطلحات موضوعية: Congenital nasolacrimal duct obstruction, CNLDO, Nasolacrimal duct probing, Epiphora, Ophthalmology, RE1-994
الوصف: Abstract Background Although nasolacrimal duct probing is the standard treatment for congenital nasolacrimal duct obstruction (CNLDO) among children, the optimal timing of this procedure has been a topic of debate. The aim of the study was to analyze the clinical efficacy of nasolacrimal duct probing among patients with CNLDO symptoms at various ages. Methods An 8-year retrospective study involved 2434 patients (3009 eyes), who underwent nasolacrimal duct probing conducted under topical anesthesia in the operating theatre. The study group consisted of 1148 girls (47.2%) and 1286 boys (52.8%) from 2 weeks to 41 months (average age was 8 ± 5.6 months). The participants were divided into nine age groups: 0–2 months, 3–6 months, 7–9 months, 10–12 months, 13–15 months, 16–18 months, 19–21 months, 22–24 months and over 24 months. Results Bilateral obstruction was present among 575 (23.6%) children and was associated with a higher percentage of unsuccessful procedures compared to patients with unilateral obstruction (16.9% vs 10.2%, p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-2415
Relation: http://link.springer.com/article/10.1186/s12886-020-01658-9; https://doaj.org/toc/1471-2415
DOI: 10.1186/s12886-020-01658-9
URL الوصول: https://doaj.org/article/f2b4c1f6d4f2452aa4812fcc0e6e91c0
رقم الأكسشن: edsdoj.f2b4c1f6d4f2452aa4812fcc0e6e91c0
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14712415
DOI:10.1186/s12886-020-01658-9